Search | IOVS | ARVO Journals

Showing 1 – 20 of 81

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Six-year results of a Phase I/IIa gene therapy trial in patients with Usher Syndrome Type-1B (USH1B)

Maria Parker; Paul Yang; Dongseok Choi; Saddek Mohand-Said; Shobana Aravind; Ambar Faridi; Elvira Chegarnov; Charles Butler; Pierre-Olivier Barale; Andreas K Lauer; Tim Stout; David Wilson; Richard Weleber; Mark E Pennesi; Jose Alain Sahel; Isabelle S Audo

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5327.

ARVO Annual Meeting Abstract June 2024

SD-OCT Features and Macular Sensitivity in ABCA4 -related Stargardt disease (STGD1)

Yanzhao WANG; Folahan Adesola Ibukun; Elias Traboulsi; David G Birch; Janet S Sunness; Rupert Strauss; Isabelle S Audo; Michel Michaelides; SriniVas R Sadda; Hendrik P Scholl; Eberhart Zrenner; Michael S Ip; Artur V Cideciyan; Paul S Bernstein; Xiangrong Kong

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):975.

ARVO Annual Meeting Abstract June 2024

Longitudinal structure-function (S-F) relationship between short-wavelength autofluorescence (SW-FAF) and macular sensitivity (MS) in ABCA4 -associated Stargardt (STGD1) disease

Folahan Adesola Ibukun; Yanzhao Wang; Artur V Cideciyan; David G Birch; Janet S Sunness; Isabelle S Audo; Michel Michaelides; Elias Traboulsi; SriniVas R Sadda; Michael S Ip; Hendrik P Scholl; Rupert Strauss; Xiangrong Kong

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3350.

ARVO Annual Meeting Abstract June 2024

Both NXNL1 and NXNL2 are important for photoreceptor survival in the mouse

Zheng LI; Imen Harichane; Ying Yang; Emmanuelle Clerin; Jose Alain Sahel; Isabelle S Audo; Christina Zeitz; Thierry Leveillard

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4771.

ARVO Annual Meeting Abstract June 2024

Spatial and anatomic parameters from SD-OCT and associations with best corrected visual acuity (BCVA) in ABCA4-associated Stargardt Disease (STGD1)

Xiangrong Kong; Yanzhao WANG; Folahan Adesola Ibukun; David G Birch; Elias Traboulsi; Janet S Sunness; Paul S Bernstein; Isabelle S Audo; Michel Michaelides; SriniVas R Sadda; Hendrik P Scholl; Eberhart Zrenner; Michael S Ip; Sheila K West; Artur V Cideciyan; Rupert Strauss

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2374.

ARVO Annual Meeting Abstract June 2024

Extensive Macular Atrophy with Pseudodrusen-like appearance (EMAP) spectrum: progression kinetics and late-stage findings

Alessio Antropoli; Lorenzo Bianco; Amine Benadji; Christel Condroyer; Aline Antonio; Julien Navarro; Christina Zeitz; Isabelle S Audo

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3122.

ARVO Annual Meeting Abstract June 2024

Full-field Electroretinogram in Extensive Macular Atrophy with Pseudodrusen-like deposits (EMAP)

Lorenzo Bianco; Alessio Antropoli; Amine Benadji; Christel Condroyer; Aline Antonio; Julien Navarro; Christina Zeitz; Isabelle S Audo

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1533.

ARVO Annual Meeting Abstract June 2024

Identification of a novel gene defect UBAP1L underlying for autosomal recessive rod-cone and cone-rod dystrophy

Isabelle S Audo; julien Navarro; Leila Azizzadeh; Cécile Méjécase; Shahad Albadri; Andrea Amprou; Tasnim Ben Yacoub; Juliette Wohlschlegel; Lorenzo Bianco; Alessio ANTROPOLI; Marco Nassisi; Said El Shameh; Vasily M. Smirnov; Jose Sahel; Filippo Del Bene; Christina Zeitz

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1518.

ARVO Annual Meeting Abstract June 2024

Vision parameters associated with worse balance in retinitis pigmentosa

Rakie Cham; Marion Losdat; Mark S Redfern; Galen Holland; Caroline de Montleau; Cécilia Coen; Isabelle S Audo; Jose Alain Sahel; Colas Nils Authié

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2574.

ARVO Annual Meeting Abstract June 2024

Assessing IRD progression over one year: performance-based testing in virtual reality with a visual search task.

Caroline Kurek; Alexis Defer; Caroline de Montleau; Cécilia Coen; Philippe Chaumet-Riffaud; Isabelle S Audo; Jose Alain Sahel; Colas Nils Authié

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3342.

ARVO Annual Meeting Abstract June 2024

Real-world safety and effectiveness of voretigene neparvovec: Year 3 interim results from the PERCEIVE study

M Dominik Fischer; Francesca Simonelli; Isabelle S Audo; Bart Peter Leroy; Line Kessel; Joao Pedro Marques; Mirjana Bjelos; James Bainbridge; Manar Aoun; Rainer Maier; Rehna Khan; Andreas Clemens; Frank G Holz

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3290.

ARVO Annual Meeting Abstract June 2024

PRODYGY: A First-in-Human Trial of Rod-Derived Cone Viability Factor (RdCVF) Gene Therapy in Subjects with Rod-Cone Dystrophy

Joseph N Martel; Isabelle S Audo; Laure Blouin; Anne-Sophie Gautron; Alice Le Meur; Nelle Messeca; Anne Celle; James A Gow; Daniel C Chung

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3091.

ARVO Annual Meeting Abstract June 2024

Evolution of Markers of Retinal Degeneration after One Year of Prospective Follow-up in Patients with Rod-Cone Dystrophy: The Natural History Study PHENOROD2

Laure Blouin; Daniel C Chung; James A Gow; Alice Le Meur; Anne Celle; Jose Alain Sahel; Joseph N Martel; Isabelle S Audo

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3090.

ARVO Annual Meeting Abstract June 2024

A novel candidate gene, DUSP4 implicated in high myopia

Christina Zeitz; Wilmet Baptiste; Christelle Michiels; Jingyi ZHANG; Helen Frederiksen; Jacques Callebert; Marie-Laure Gimenez; Catherine W Morgans; Robert Duvoisin; Linda Horan; Robin Plevin; Jose Sahel; Serge A Picaud; Isabelle S Audo

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6152.

ARVO Annual Meeting Abstract June 2023

Mobility and Postural Testing in Patients with Rod-Cone Dystrophy Enrolled in the Prospective Natural History Study PHENOROD2

Mylène Poujade; Laure Blouin; Colas Nils Authié; Daniel C Chung; Alice Le Meur; KEVIN NEUFER; Anne Celle; Jose Sahel; Isabelle S Audo

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4644.

ARVO Annual Meeting Abstract June 2023

Complete congenital stationary night blindness as a tool to study myopia

Wilmet Baptiste; Jérome Roger; Christelle Michiels; Jacques Callebert; Robert Duvoisin; Juliette Varin; Nuria Sánchez-Farías; Frank Schaeffel; José-Alain Sahel; Isabelle S Audo; Christina Zeitz

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5235.

ARVO Annual Meeting Abstract June 2023

SLC24A1 mutations are a cause of autosomal recessive retinitis pigmentosa

Imran H Yusuf; Richard Caswell; Parveen Sen; Maria Vadala; Patrik Schatz; Said El Shamieh; Srilekha Sundaramurthy; Sinje Geuer; Isabelle Meunier; Christina Zeitz; Isabelle S Audo; Inmaculada Martin-Merida; Carmen Ayuso; Ajoy Vincent; Andrew R Webster; Peter Charbel Issa

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5441.

ARVO Annual Meeting Abstract June 2023

Visual search with natural scenes: validation of a new virtual reality outcome in inherited retinal disease.

Caroline Kurek; Alireza Talebi; Alexis Defer; Saddek Mohand-Said; Philippe Chaumet-Riffaud; Isabelle S Audo; Jose Sahel; Colas Nils Authié

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5526.

ARVO Annual Meeting Abstract June 2023

Isolated and syndromic retinal degeneration associated with POC5 variants.

Vasily M. SMIRNOV; Claire-Marie Dhaenens; Grunewald Olivier; Christel Condroyer; Aline Antonio; Jose Sahel; Christina Zeitz; Isabelle S Audo

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4522.

ARVO Annual Meeting Abstract June 2023

Development of a real-life mobility test for the performance evaluation of advanced retinitis pigmentosa subjects

Chloé Pagot; Mylène Poujade; Karine Becker; Suzon Ajasse; Cécilia Coen; Caroline De Montleau; Magali Taiel; Saddek Mohand-Said; Jose Sahel; Isabelle S Audo

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5041.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Specify Date Range

Six-year results of a Phase I/IIa gene therapy trial in patients with Usher Syndrome Type-1B (USH1B)

SD-OCT Features and Macular Sensitivity in ABCA4 -related Stargardt disease (STGD1)

Longitudinal structure-function (S-F) relationship between short-wavelength autofluorescence (SW-FAF) and macular sensitivity (MS) in ABCA4 -associated Stargardt (STGD1) disease

Both NXNL1 and NXNL2 are important for photoreceptor survival in the mouse

Spatial and anatomic parameters from SD-OCT and associations with best corrected visual acuity (BCVA) in ABCA4-associated Stargardt Disease (STGD1)

Extensive Macular Atrophy with Pseudodrusen-like appearance (EMAP) spectrum: progression kinetics and late-stage findings

Full-field Electroretinogram in Extensive Macular Atrophy with Pseudodrusen-like deposits (EMAP)

Identification of a novel gene defect UBAP1L underlying for autosomal recessive rod-cone and cone-rod dystrophy

Vision parameters associated with worse balance in retinitis pigmentosa

Assessing IRD progression over one year: performance-based testing in virtual reality with a visual search task.

Real-world safety and effectiveness of voretigene neparvovec: Year 3 interim results from the PERCEIVE study

PRODYGY: A First-in-Human Trial of Rod-Derived Cone Viability Factor (RdCVF) Gene Therapy in Subjects with Rod-Cone Dystrophy

Evolution of Markers of Retinal Degeneration after One Year of Prospective Follow-up in Patients with Rod-Cone Dystrophy: The Natural History Study PHENOROD2

A novel candidate gene, DUSP4 implicated in high myopia

Mobility and Postural Testing in Patients with Rod-Cone Dystrophy Enrolled in the Prospective Natural History Study PHENOROD2

Complete congenital stationary night blindness as a tool to study myopia

SLC24A1 mutations are a cause of autosomal recessive retinitis pigmentosa

Visual search with natural scenes: validation of a new virtual reality outcome in inherited retinal disease.

Isolated and syndromic retinal degeneration associated with POC5 variants.

Development of a real-life mobility test for the performance evaluation of advanced retinitis pigmentosa subjects

To View More...

You must be signed into an individual account to use this feature.